Detalhe da pesquisa
1.
MYC determines lineage commitment in KRAS-driven primary liver cancer development.
J Hepatol
; 79(1): 141-149, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36906109
2.
Design and Optimization of Novel Benzimidazole- and Imidazo[4,5-b]pyridine-Based ATM Kinase Inhibitors with Subnanomolar Activities.
J Med Chem
; 66(11): 7304-7330, 2023 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37226670
3.
Development of novel urea-based ATM kinase inhibitors with subnanomolar cellular potency and high kinome selectivity.
Eur J Med Chem
; 235: 114234, 2022 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35325634